ONX-0801
ONX-0801[edit | edit source]
ONX-0801 is a novel antifolate drug that has been investigated for its potential use in the treatment of cancer. It is designed to target the folate receptor alpha (FR_), which is overexpressed in certain types of cancer cells, including ovarian cancer and non-small cell lung cancer.
Mechanism of Action[edit | edit source]
ONX-0801 functions as a targeted antifolate agent. It inhibits the enzyme thymidylate synthase, which is crucial for DNA synthesis and cell division. By selectively binding to the folate receptor alpha, ONX-0801 is preferentially taken up by cancer cells that overexpress this receptor, thereby minimizing effects on normal cells and reducing toxicity.
Clinical Development[edit | edit source]
ONX-0801 has undergone clinical trials to evaluate its safety and efficacy. Early-phase trials have shown promising results, particularly in patients with FR_-positive tumors. The drug's ability to selectively target cancer cells offers a potential advantage over traditional chemotherapy agents, which often affect both cancerous and healthy cells.
Potential Benefits[edit | edit source]
The targeted nature of ONX-0801 may lead to fewer side effects compared to conventional chemotherapy. This specificity could result in improved quality of life for patients undergoing treatment. Additionally, the drug's mechanism of action provides a new therapeutic option for patients with tumors that are resistant to other forms of treatment.
Challenges and Future Directions[edit | edit source]
Despite its potential, ONX-0801 faces challenges in its development. These include the need for reliable biomarkers to identify patients who would benefit most from the treatment and the management of any unforeseen side effects. Ongoing research is focused on optimizing dosing regimens and exploring combination therapies with other anticancer agents.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
